Primary HPV screening for cervical cancer.
Bhatla N, Singhal S.
Best Pract Res Clin Obstet Gynaecol. 2020 May;65:98-108. doi: 10.1016/j.bpobgyn.2020.02.008. Epub 2020 Mar 2.
Mild cervical dysplasia. Experience in a family planning clinic.
Sondheimer SJ, Casey MV, Rubin M, Mangan C, Atkinson B, Huggins GR.
J Reprod Med. 1983 Jul;28(7):489-95.
Efficacy of a Coriolus versicolor-Based Vaginal Gel in Women With Human Papillomavirus-Dependent Cervical Lesions: The PALOMA Study.
Serrano L, López AC, González SP, Palacios S, Dexeus D, Centeno-Mediavilla C, Coronado P, de la Fuente J, López JA, Vanrell C, Cortés J.
J Low Genit Tract Dis. 2021 Apr 1;25(2):130-136. doi: 10.1097/LGT.0000000000000596.
Cervical dysplasia and human papillomavirus.
Carmichael JA, Maskens PD.
Am J Obstet Gynecol. 1989 Apr;160(4):916-8. doi: 10.1016/0002-9378(89)90310-4.
Proliferation and DNA aneuploidy in mild dysplasia imply early steps of cervical carcinogenesis.
Steinbeck RG.
Acta Oncol. 1997;36(1):3-12. doi: 10.3109/02841869709100723.
Digital analysis and quantitative assessment of the cervical surface with dysplasia.
Dushkin AD, Afanasiev MS, Zatevalov AM, Aleshkin VA, Mironov AY, Afanasiev SS, Nesvizhsky YV, Borisova OY, Grishacheva TG, Karaulov AV.
Klin Lab Diagn. 2021 Jul 16;66(7):417-421. doi: 10.51620/0869-2084-2021-66-7-417-421.
Evaluation of mild-to-moderate dysplasia on cervical-endocervical (Pap) smear: a subgroup of patients who bridge LSIL and HSIL.
McGrath CM, Kurtis JD, Yu GH.
Diagn Cytopathol. 2000 Oct;23(4):245-8. doi: 10.1002/1097-0339(200010)23:4<245::aid-dc6>3.0.co;2-7.
Determinants of high-grade dysplasia among women with mild dyskaryosis on cervical smear.
Parazzini F, Sideri M, Restelli S, Schettino F, Chatenoud L, Crosignani PG.
Obstet Gynecol. 1995 Nov;86(5):754-7. doi: 10.1016/0029-7844(95)00281-u.
Laser miniconization procedure.
Békássy Z.
Int J Gynaecol Obstet. 1996 Dec;55(3):237-46. doi: 10.1016/s0020-7292(96)02767-1.
Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial.
Meyskens FL Jr, Surwit E, Moon TE, Childers JM, Davis JR, Dorr RT, Johnson CS, Alberts DS.
J Natl Cancer Inst. 1994 Apr 6;86(7):539-43. doi: 10.1093/jnci/86.7.539.
